Simulated daily plan adaptation for magnetic resonance-guided liver stereotactic body radiotherapy

被引:0
|
作者
Taylor, Edward [1 ,2 ]
Lukovic, Jelena [1 ,2 ]
Velec, Michael [1 ,2 ]
Shessel, Andrea [1 ]
Stanescu, Teodor [1 ,2 ]
Dawson, Laura [1 ,2 ]
Letourneau, Daniel [1 ,2 ]
Lindsay, Patricia [1 ,2 ]
机构
[1] Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada
关键词
Image guided radiotherapy; magnetic resonance imaging; liver cancer; stereotactic body radiotherapy; RADIATION-THERAPY SMART; MALIGNANCIES; ABDOMEN; PELVIS; THORAX; IMPACT;
D O I
10.1080/0284186X.2020.1840625
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction Liver cancers are challenging to treat using image-guided radiotherapy (IGRT) due to motion and deformation of target volumes and organs at risk (OARs), as well as difficulties in visualising liver tumours using cone-beam computed tomography (CBCT) based IGRT. Liver cancer patients may thus benefit from magnetic resonance (MR)-guided daily adaptive re-planning. We evaluated the dosimetric impact of a daily plan adaptation strategy based on daily MR imaging versus CBCT-based IGRT. Methods Ten patients were studied who were treated with CBCT-guided five-fraction stereotactic body radiotherapy (SBRT) and underwent MR imaging before each fraction. Simulated reference plans were created on computer tomography (CT) images and adapted plans were created on the daily MR images. Two plan adaptation strategies were retrospectively simulated: (1) translational couch shifts to match liver, mimicking standard CBCT guidance and (2) daily plan adaptation based on reference plan clinical goals and daily target and OAR contours. Dose statistics were calculated for both strategies and compared. Results Couch shifts resulted in an average reduction in GTV D99% relative to reference plan values of 5.2 Gy (-12.5% of reference values). Daily plan adaptation reduced this to 0.8 Gy (-2.0%). For six patients who were OAR dose-limited on reference plans, couch shifts resulted in OAR dose violations in 28 out of 28 simulated fractions, respectively; no violations occurred using daily plan adaptation. No OAR dose violations occurred using either strategy for the four cases not OAR dose-limited at reference planning. Conclusions MR-guided daily plan adaptation ensured OAR dose constraints were met at all simulated treatment fractions while CBCT-based IGRT resulted in a systematic over-dosing of OARs in patients whose doses were limited by OAR dose at the time of reference planning.
引用
收藏
页码:260 / 266
页数:7
相关论文
共 50 条
  • [21] Impact of magnetic resonance-guided versus conventional radiotherapy workflows on organ at risk doses in stereotactic body radiotherapy for lymph node oligometastases
    Werensteijn-Honingh, Anita M.
    Kroon, Petra S.
    Winkel, Dennis
    van Gaal, J. Carlijn
    Hes, Jochem
    Snoeren, Louk M. W.
    Timmer, Jaleesa K.
    Mout, Christiaan C. P.
    Bol, Gijsbert H.
    Kotte, Alexis N.
    Eppinga, Wietse S. C.
    Intven, Martijn
    Raaymakers, Bas W.
    Jurgenliemk-Schulz, Ina M.
    PHYSICS & IMAGING IN RADIATION ONCOLOGY, 2022, 23 : 66 - 73
  • [22] Clinical Outcomes of Online Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Adrenal Metastases from a Single Institution
    Hoegen-Sassmannshausen, Philipp
    Jessen, Inga
    Buchele, Carolin
    Schlueter, Fabian
    Rippke, Carolin
    Renkamp, Claudia Katharina
    Weykamp, Fabian
    Regnery, Sebastian
    Liermann, Jakob
    Meixner, Eva
    Hoeltgen, Line
    Eichkorn, Tanja
    Koenig, Laila
    Debus, Juergen
    Klueter, Sebastian
    Hoerner-Rieber, Juliane
    CANCERS, 2024, 16 (12)
  • [23] Magnetic Resonance-Guided Stereotactic Laser Pallidotomy for Dystonia
    Gross, Robert E.
    Stern, Matthew A.
    MOVEMENT DISORDERS, 2018, 33 (09) : 1502 - 1503
  • [24] Dosimetric benefits of daily treatment plan adaptation for prostate cancer stereotactic body radiotherapy
    Miriam Eckl
    Gustavo R. Sarria
    Sandra Springer
    Marvin Willam
    Arne M. Ruder
    Volker Steil
    Michael Ehmann
    Frederik Wenz
    Jens Fleckenstein
    Radiation Oncology, 16
  • [25] Dosimetric benefits of daily treatment plan adaptation for prostate cancer stereotactic body radiotherapy
    Eckl, Miriam
    Sarria, Gustavo R.
    Springer, Sandra
    Willam, Marvin
    Ruder, Arne M.
    Steil, Volker
    Ehmann, Michael
    Wenz, Frederik
    Fleckenstein, Jens
    RADIATION ONCOLOGY, 2021, 16 (01)
  • [26] Impact of daily plan adaptation on accumulated doses in ultra-hypofractionated magnetic resonance-guided radiation therapy of prostate cancer
    Xiong, Yuqing
    Rabe, Moritz
    Rippke, Carolin
    Kawula, Maria
    Nierer, Lukas
    Klueter, Sebastian
    Belka, Claus
    Niyazi, Maximilian
    Hoerner-Rieber, Juliane
    Corradini, Stefanie
    Landry, Guillaume
    Kurz, Christopher
    PHYSICS & IMAGING IN RADIATION ONCOLOGY, 2024, 29
  • [27] MAGNETIC RESONANCE-GUIDED ADAPTIVE RADIOTHERAPY REDUCES THE NORMAL TISSUE COMPLICATION PROBABILITY OF ADRENAL STEREOTACTIC ABLATIVE RADIOTHERAPY
    Chen, Hanbo
    de Koste, John van Sornsen
    Bohoudi, Omar
    Slotman, Ben
    Palacios, Miguel
    Senan, Suresh
    Lagerwaard, Frank
    RADIOTHERAPY AND ONCOLOGY, 2020, 150 : S82 - S82
  • [28] Stereotactic Magnetic Resonance-guided Online Adaptive Radiotherapy for Oligometastatic Breast Cancer: A Case Report
    Tyran, Marguerite
    Cao, Minsong
    Raldow, Ann C.
    Dang, Audrey
    Lamb, James
    Low, Daniel A.
    Steinberg, Michael L.
    Lee, Percy
    CUREUS, 2018, 10 (03):
  • [29] Feasibility of quantitative relaxometry for prostate target localization and response assessment in magnetic resonance-guided online adaptive stereotactic body radiotherapy
    Subashi, Ergys
    Locastro, Eve
    Burleson, Sarah
    Apte, Aditya
    Zelefsky, Michael
    Tyagi, Neelam
    PHYSICS & IMAGING IN RADIATION ONCOLOGY, 2024, 32
  • [30] Magnetic Resonance-Guided Adaptive Radiotherapy: A Solution to the Future
    Kupelian, Patrick
    Sonke, Jan-Jakob
    SEMINARS IN RADIATION ONCOLOGY, 2014, 24 (03) : 227 - 232